CEACAM1 is a potent regulator of B cell receptor complex-induced activation

被引:52
作者
Greicius, G
Severinson, E
Beauchemin, N
Öbrink, B
Singer, BB
机构
[1] Karolinska Inst, CMB, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden
[2] McGill Univ, McGill Canc Ctr, Montreal, PQ, Canada
关键词
rodent; B lymphocytes; coregulation; cellular proliferation; adhesion molecules;
D O I
10.1189/jlb.1202594
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1, CD66a) is a member of the immunoglobulin (Ig) superfamily, previously characterized as an adhesion and signaling molecule in epithelial, endothelial, and hematopoietic cells. Here, we show that the CEACAM1 isoform expression pattern is different in nonactivated and activated primary mouse B lymphocytes and that CEACAM1 influences B cell receptor complex-mediated activation. A CEACAM1-specific monoclonal antibody strongly triggered proliferation of mouse B cells when combined with surface IgM cross-linking. However, anti-CEACAM1 was not mitogenic when added alone. The proliferation was more pronounced and lasted longer as compared with other activators of B cells, such as anti-IgM in the presence of interleukin-4 or lipopolysaccharide. A similar, costimulatory effect was exerted by CEACAM1-expressing fibroblasts, indicating that homophilic CEACAM1-CEACAM1 cell-mediated binding is the physiological stimulus for CEACAM1-triggered B cell signaling. The anti-CEACAM1/anti-IgM-activated cells aggregated in a lymphocyte function-associated antigen-1-dependent manner. Furthermore, cells that were activated by anti-CEACAM1/anti-IgM secreted Ig but did not go through Ig class-switching. Anti-CEACAM1 induced phosphorylation of c-Jun N-terminal kinase (stress-activated protein kinase) but did not activate the extracellular signal-regulated kinase or p38 mitogen-activated protein kinases.
引用
收藏
页码:126 / 134
页数:9
相关论文
共 50 条
[21]   Notch1 enhances B-cell receptor-induced apoptosis in mature activated B cells without affecting cell cycle progression and surface IgM expression [J].
S Romer ;
U Saunders ;
H-M Jäck ;
B M Jehn .
Cell Death & Differentiation, 2003, 10 :833-844
[22]   Notch1 enhances B-cell receptor-induced apoptosis in mature activated B cells without affecting cell cycle progression and surface IgM expression [J].
Romer, S ;
Saunders, U ;
Jäck, HM ;
Jehn, BM .
CELL DEATH AND DIFFERENTIATION, 2003, 10 (07) :833-844
[23]   Immune complex-driven neutrophil activation and BAFF release: a link to B cell responses in SLE [J].
Wang, Ting ;
Vasconcellos, Andrew ;
Marken, John ;
Skopelja-Gardner, Sladjana ;
Lood, Christian ;
Giltiay, Natalia, V .
LUPUS SCIENCE & MEDICINE, 2022, 9 (01)
[24]   The molecular mechanism of B cell activation by toll-like receptor protein RP-105 [J].
Chan, VWF ;
Mecklenbräuker, I ;
Su, IH ;
Texido, G ;
Leitges, M ;
Carsetti, R ;
Lowell, CA ;
Rajewsky, K ;
Miyake, K ;
Tarakhovsky, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (01) :93-101
[25]   Tocilizumab modulates activation and homing receptor of peripheral memory B cell subsets in rheumatoid arthritis patients [J].
Mahmood, Zafar ;
Schmalzing, Marc ;
Doerner, Thomas ;
Tony, Hans Peter ;
Muhammad, Khalid .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 :188-188
[26]   The immune response modifier resiquimod mimics CD40-induced B cell activation [J].
Bishop, GA ;
Ramirez, LM ;
Baccam, M ;
Busch, LK ;
Pederson, LK ;
Tomai, MA .
CELLULAR IMMUNOLOGY, 2001, 208 (01) :9-17
[27]   Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization [J].
van Pel, M ;
van Os, R ;
Velders, GA ;
Hagoort, H ;
Heegaard, PMH ;
Lindley, IJD ;
Willemze, R ;
Fibbe, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (05) :1469-1474
[28]   B cell receptor induced Fc receptor-like 5 expression is mediated by multiple signaling pathways converging on NF-κB and NFAT [J].
Damdinsuren, Bazarragchaa ;
Dement-Brown, Jessica ;
Li, Huifang ;
Tolnay, Mate .
MOLECULAR IMMUNOLOGY, 2016, 73 :112-121
[29]   B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus [J].
Goeken, J. A. ;
Layer, T. ;
Fleenor, S. ;
Laccheo, M. ;
Lenert, P. .
LUPUS, 2010, 19 (11) :1290-1301
[30]   Activation of Toll-like receptor 9 inhibits lipopolysaccharide-induced receptor activator of nuclear factor kappa- B ligand expression in rat B lymphocytes [J].
Yu, Xiaoqian ;
Lin, Jiang ;
Yu, Qing ;
Kawai, Toshihisa ;
Taubman, Martin A. ;
Han, Xiaozhe .
MICROBIOLOGY AND IMMUNOLOGY, 2014, 58 (01) :51-60